This website uses cookies files. By continuing to browse this site you are agreeing to our cookies policy Cookie policy

You are here: Home InvestmentsEquity funds Esaliens Medicine & New Technology (until 19.10.2021 Esaliens Strategist)

Esaliens Medicine & New Technology (until 19.10.2021 Esaliens Strategist)

A subfund of ESA Umbrella OEIF The subfund is available within products with tax preferences

Subfund's details

Subfund type 
Equity subfund
Incepition date
4 January 1999
Minimum investment
PLN 100
Maximum initial fee (A units)
4%
Management fee (A units)

2.46%
Account No. for purchases
70 1050 0086 1000 0090 3004 5067
Benchmark
-

Performance chart

The chart presents performance of class A unitsInvest online
Selected dates scope:
  • PRICES
  • PERFORMANCE

Error occured,

Try again later.

Module.Fund.Errors.ChartHeaderNoData,

Module.Fund.Errors.ChartTextNoData.

Performance*
Period ESA Medicine & New Technology
1 month -14.36%
3 months -17.22%
6 months -16.42%
12 months -6.61%
36 months 4.55%
60 months 3.04%
YTD -14.37%
* Performance of class A units, 26-01-2022

Risk profile

6 - high risk

asset allocation

Model allocation - up to 100% of subfund's portfolio invested in shares.

Investor's profile

The subfund is designed for an investor who:

  • expects to achieve a rate of return on investment in shares of companies whose activities are related to health protection or new technologies. 
  • accepts high investment risk,
  • is looking for a fund with an active, selective management style (careful selection of valuable enterprises),
  • avoids market-timing strategy (forecasting stock market trends and building portfolios for the short-term expected and anticipated event scenario),
  • is looking for a wide diversification of the portfolio of companies, minimizing the risk of a single company.
The subfund is designed i.a. for regular investing within long-term saving and pension schemes (regular saving plans (CPO), individual retirement accounts (IKE), individual pension security accounts (IKZE), occupational pension schemes (PPE)).
The evaluation of fund’s performance should not be made for a period shorter than 3 years.

additional information

Transfer Agent

Pekao Financial Services Sp. z o.o.

Custodian

ING Bank Śląski S.A. w Katowicach



Investment Process

ESALIENS Medicine & New Technology Subfund invests from 60% to 100% of its assets in equity securities of companies listed on the regulated market. As a part of the investment objective, the Fund invests primarily in shares of companies whose activities are related to health protection or new technologies, as well as other types of investments.

The Fund may invest the Subfund's Assets in other investments, in particular debt securities or Money Market Instruments, in order to ensure the Subfund's liquidity and minimize the risk of impairment of the Shares in periods of downturn on the stock market.



Literature

ESALIENS Medicine & New Technology - Fact card 169.11 KB

Esaliens Medicine & New Technology

Start investing now!

Invest online

Important information

The fund do not guarantee that the investment objective or a specific investment result will be achieved. Before investing, you should read the Prospectus and the Key Investor Information Documents. The Prospectus as well as the Key Investor Information Documents include the data required to evaluate an investment, outline the risks connected with participation in the fund, and inform on the related costs, charges and taxes. Read the full text of the important information

COMFORTABLY AND EASY!

Esaliens24 application for you
Monitor your savings and control your investment portfolio

go up